Pembrolizumab-induced hypothyroidism manifesting as myopathy and psychosis

Melanoma Res. 2021 Aug 1;31(4):405-406. doi: 10.1097/CMR.0000000000000759.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Humans
  • Hypothyroidism / chemically induced*
  • Male
  • Middle Aged
  • Muscular Diseases / chemically induced*
  • Psychotic Disorders / etiology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • pembrolizumab